Company Snapshot
- Ticker
- ZTS
- Name
- ZTS
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 53582042000.000000
- Volume
- 7,137,874
- Avg Volume (3M)
- 3,663,624
ZTS
ZTS
Last update recent
120.98
+2.32
(+1.96%)
Market Cap
53582042000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 9397000000.000000
- EPS
- 5.94
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 1.61%
- Net Income
- 2651000000.000000
- Net Margin
- 28.21%
- Payout Ratio
- 32.55%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 20.21
- Forward P/E
- None
- P/S
- 5.70
- P/B
- 9.93
- Beta
- None
- Debt / Equity
- 1.35
- Current Ratio
- 3.64
- Return on Equity
- 0.49%
- Return on Assets
- 0.17%
Technicals & Returns
- Distance vs 200 DMA
- -18.78%
- 200 DMA
- 148.95
- Distance vs 50 DMA
- -7.38%
- 50 DMA
- 130.62
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteri Read more
- Name
- ZTS
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Kristin C. Peck
- Employees
- 14,100
- IPO Date
- 2013-02-01
- Phone
- 973 822 7000
- Address
- None
- Website
- https://www.zoetis.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-07-18 • $0.432
Latest News
Curated headlines from premium sources.
Here Are Monday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, GE Vernova, KLA Corp., Klaviyo, Las Vegas Sands, ServiceNow, and More
Pre-Market Stock Futures: Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard on Frida…
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that, subject to market condition…
Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors
Chewy Inc. gained 12% during the quarter as the company delivered solid results driven by higher autoship subscription activity and expanding private-label off…
Caldwell Trust Co Takes Position in Zoetis Inc. $ZTS
Caldwell Trust Co purchased a new stake in shares of Zoetis Inc. (NYSE: ZTS) during the undefined quarter, according to its most recent filing with the Securit…
Zoetis Inc. $ZTS Shares Acquired by BlueSpruce Investments LP
BlueSpruce Investments LP increased its position in shares of Zoetis Inc. (NYSE: ZTS) by 21,663.1% during the second quarter, according to the company in its m…
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the f…